Originally developed to treat type 2 diabetes, clinical studies show that semaglutide can help patients lose 1522% of body weight when combined with lifestyle changes
In experiments in mice it has been shown that deletion of CPT-1C results in reduced feeding behavior and lowered body weight similar to studies in which hypothalamic malonyl-CoA levels are elevated
Are there FDA-approved formulations available for my specific regimen, and if you're prescribing compounded preparations, what's the clinical reasoning for that choice
10.1016/j.peptides.2017.12.002 4 BeiroaD.ImbernonM.GallegoR.SenraA.HerranzD.VillarroyaF.et al (2014)
Because of the increased vascular permeability and breakdown of the blood-retinal barrier, fluid and lipids leak into the retina and cause it to swell
June 2025 Medicaid & CHIP enrollment data highlights, Centers for Medicare & Medicaid Services (2025) Medicaid utilization and spending on new drugs used for weight loss, KFF (2023) H.R.1 Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress.gov Medicaid utilization and spending on new drugs used for weight loss, KFF (2023) Beneficiary resources, Centers for Medicare & Medicaid Services Cost sharing, Centers for Medicare & Medicaid Services Current and resolved drug shortages and discontinuations reported to FDA, U.S